These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33761028)

  • 1. Bayesian modeling of health state preferences: could borrowing strength from existing countries' valuations produce better estimates.
    Kharroubi SA; Beyh Y
    Eur J Health Econ; 2021 Jul; 22(5):773-788. PubMed ID: 33761028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?
    Kharroubi SA
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?
    Kharroubi SA; Rowen D
    Eur J Health Econ; 2019 Mar; 20(2):245-255. PubMed ID: 29980950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2014 Jun; 17(4):397-405. PubMed ID: 24969000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Non-parametric Bayesian Method to Model Health State Preferences: An Application to Polish and Irish EQ-5D-5L Valuations.
    Kharroubi SA; Kelleher D
    Front Public Health; 2022; 10():917728. PubMed ID: 35812518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.
    Kharroubi SA
    Health Qual Life Outcomes; 2017 Oct; 15(1):195. PubMed ID: 28985757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
    Kharroubi SA
    Appl Health Econ Health Policy; 2015 Aug; 13(4):409-20. PubMed ID: 25896874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling SF-6D health state preference data using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; Roberts J; O'Hagan A
    J Health Econ; 2007 May; 26(3):597-612. PubMed ID: 17069909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Bayesian methods to model the SF-6D health state preference based data.
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating a preference-based index from the Japanese SF-36.
    Brazier JE; Fukuhara S; Roberts J; Kharroubi S; Yamamoto Y; Ikeda S; Doherty J; Kurokawa K
    J Clin Epidemiol; 2009 Dec; 62(12):1323-31. PubMed ID: 19615856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.
    Thomas S; Johnson JA; Xie F
    Qual Life Res; 2020 Nov; 29(11):3109-3118. PubMed ID: 32705459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian Nonparametric Approach for Modeling SF-6D Health State Utility Scores.
    Kharroubi SA
    Value Health Reg Issues; 2022; 27():1-11. PubMed ID: 34784542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Portuguese and UK health state values differ across valuation methods?
    Ferreira LN; Ferreira PL; Rowen D; Brazier JE
    Qual Life Res; 2011 May; 20(4):609-19. PubMed ID: 21061071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
    Kharroubi SA; Beyh YS; Brazier J; Yang Y
    Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.